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Chemistry-Based Functional Proteomics
Reveals Novel Members
of the Deubiquitinating Enzyme Family
based on the chemical reactivity toward known target
proteins. Such approaches have been utilized to target
the serine hydrolases and cysteine proteases [2, 3].
Here, we apply a similar strategy to an enzyme class in
the ubiquitin-proteasome system.
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an essential player in nonlysosomal protein turnover,200 Longwood Avenue
Boston, Massachusetts 02115 regulation of the cell cycle, membrane receptor endocy-
tosis, and antigen presentation [4]. Several enzyme fami-2 Department of Biochemistry
4017 Rollins Research Building lies cooperate to tag proteins with ubiquitin (Ub); ubiqui-
tinated proteins are then delivered to the proteasomeEmory University Medical School
1510 Clifton Road for degradation or are destined for other cellular fates
[5]. Deubiquitinating enzymes (DUBs), which remove UbAtlanta, Georgia 30322
from substrate proteins, also regulate the ubiquitin-pro-
teasome system [6]. USP7 (HAUSP) can remove Ub from
the p53 tumor suppressor and rescue it from degrada-Summary
tion, allowing p53-mediated cell growth repression [7].
Many key cell cycle regulatory proteins are degraded inThe ubiquitin (Ub)-proteasome system includes a large
family of deubiquitinating enzymes (DUBs). Many a Ub-dependent manner [5], and DUBs therefore are
likely participants in the regulation of their activity levels.members are assigned to this enzyme class by se-
quence similarity but without evidence for biological Indeed, several known and putative DUBs, such as
CYLD1, BAP1, and Tre-2, are thought to function asactivity. A panel of novel DUB-specific probes was
generated by a chemical ligation method. These tumor suppressors [8-10]. Regulated deubiquitination is
likewise observed for proteins that are not targeted toprobes allowed identification of DUBs and associated
components by tandem mass spectrometry, as well the proteasome. Ub is removed from histone H2A during
mitotic and apoptotic chromatin condensation [11, 12];as rapid demonstration of enzymatic activity for gene
products whose functions were inferred from primary similarly, Ub is removed from membrane receptors by
the yeast Doa4 during endocytosis and targeting to thestructure. We identified 23 active DUBs in EL4 cells,
including the tumor suppressor CYLD1. At least two vacuole [13]. These observations, as well as the tissue-
specific expression of many DUBs, suggest that eachDUBs tightly interact with the proteasome 19S regula-
tory complex. An OTU domain-containing protein, with DUB may be dedicated to a specific substrate(s) [6].
However, the activity of DUBs in complex samples, suchno sequence homology to any known DUBs, was iso-
lated. We show that this polypeptide reacts with the as mammalian cells or extracts prepared from them, has
been difficult to examine, since many of these enzymesC terminus of Ub, thus demonstrating DUB-like enzy-
matic activity for this novel superfamily of proteases. (over 40 in mammalian genomes) are present in the cell.
DUBs belong to two subfamilies of cysteine proteases
with no sequence homology. All DUBs are exquisitelyIntroduction
specific for the hydrolysis of a peptide bond at the C
terminus of Ub. Most DUBs can bind a Ub monomer,The sequencing of genomes of many organisms pro-
vides a wealth of information, the meaningful interpreta- even if the monomer is not the preferred substrate in
vivo [6]. We therefore designed active site-directedtion of which is a major challenge. Proteins can be classi-
fied into distinct families based on sequence similarity, probes that contain an epitope-tagged Ub (HAUb) with
a C-terminal thiol-reactive group that can act as suicideyet this alone does not always accurately predict func-
tion. Alternative methods for rapid assignment of biolog- substrates. Having shown that ubiquitin vinyl sulfone
(UbVS) modifies 6 out of 17 DUBs in budding yeastical activity to newly sequenced proteins are therefore
[14], we designed six additional thiol-reactive groups torequired. Sequence comparison for proteins that do not
target a wider range of DUBs.possess enzymatic activity provides information about
Here we report the synthesis of HAUb-derived probesshared structural elements, such as Ig folds in the Ig
using an intein-based chemical ligation method [15, 16]superfamily [1]. The roles of such common sequence
and show that their reactivity toward DUBs dependsmotifs are frequently divergent and hold few clues to
on the type of C-terminal electrophile used. Enzymesfunction. Sequence comparison of catalytically active
modified by the HAUb-derived probes were isolated andproteins may be more readily interpretable; neverthe-
identified by tandem mass spectrometry. We show thatless, assignment of a protein to an enzyme class re-
23 DUBs are targeted by these probes in EL4 cell lysates,quires the experimental demonstration of its activity.
including 10 polypeptides for which no enzymatic activ-Novel members of an enzyme family can be identified
ity has been previously demonstrated. Furthermore,by designing active site-directed probes, which are
subunits of the 19S cap of the proteasome can be recov-
ered in association with active DUBs. A gene product3 Correspondence: ploegh@hms.harvard.edu
4 These authors contributed equally to this work. suspected of being a thiol protease, with no sequence
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Figure 1. Synthesis of HAUb-Derived Probes
(A) The intein-based chemical ligation
method. Recombinant HAUb75-intein-chitin
binding domain (CBD) fusion protein was
bound to a chitin affinity column; on-column
cleavage of the HAUb-intein junction was in-
duced by the addition of -mercaptoethane
sulfonic acid (MESNa). The resulting HAUb75-
MESNa thioester was reacted with a desired
C-terminal thiol-reactive group as described
in Experimental Procedures, generating the
desired HAUb-derived probe.
(B) Site of attack of a hydrolase on the peptide
bond at the C terminus of Ub.
(C) Structures of C-terminal thiol-reactive
groups used.
homology to DUBs (containing an ovarian tumor [OTU] bromopropyl (HAUbBr3). The use of simple alkylhalides
as protease inhibitors has not been previously reported.domain [17]), was also found to be reactive with C-ter-
minally modified Ub. This approach can be extended to All probes (except HAUbBr3) were designed to react at
a position that corresponds to the C-terminal carbonylany class of enzymes that can be targeted covalently
and help assign enzymatic activity to new gene of the Gly76 amide bond conjugating Ub to its substrate
(Figure 1B). Based on their chemical reactivity, the elec-products.
trophiles used are expected to differ in their ability to
modify DUBs and consequently may selectively labelResults
different molecular targets. Recombinant, purified UCH-
L3 enzyme [20] was reacted with the HAUb-derivedSynthesis and Characterization
probes. An additional polypeptide of a molecular massof HAUb–Derived Probes
consistent with covalently modified UCH-L3 was ob-The strategy for the synthesis of active site-directed
served for all probes, confirming their ability to targetprobes is outlined in Figure 1A. N-terminally HA-tagged
deubiquitinating enzymes (data not shown). Full-lengthUb (HAUb) lacking Gly76 was expressed in E. coli as a
HAUb was also generated by chemical ligation with gly-fusion protein with an intein and a chitin binding domain
cine and was shown to be incorporated into poly-Ub[16]. Purification over chitin-beads, followed by trans-
conjugates (Figure 2, lane 2). Thus, the presence of anthioesterification led to the isolation of the desired thio-
HA tag does not adversely affect interaction with en-ester (HAUb75-MESNa). Desired irreversible inhibitors
zymes that utilize Ub.were synthesized by chemical ligation of the reactive
groups (Figure 1C) with HAUb75-MESNa in 50%–90%
yield and purified by cation-exhange chromatography. Profiling Enzymes Modified by HAUb-Derived
Probes in EL-4 Cell ExtractsThe molecular weights of the pure HAUb derivatives
were in agreement with the predicted masses, as as- To address the specificity of the HAUb-derived probes
toward DUBs, we carried out labeling experiments usingsessed by mass spectrometry (LC-ESI-MS, see Supple-
mental Data). The intein-based chemical ligation ap- whole-cell lysates. The EL4 mouse thymoma cell line
was selected for this purpose, since it expresses a di-proach is amendable to the introduction of diverse
chemical groups at the C terminus of Ub and gives verse set of deubiquitinating enzymes [14]. The enzymes
modified were visualized by anti-HA immunoblottingproducts of greater purity and at higher yield then the
reverse trypsinolysis method used previously [14]. after incubation with HAUb-derived probes (Figure 2).
We observed distinct profiles of labeled polypeptidesSeven HAUb-derived probes with different C-terminal
electrophilic traps were generated (Figure 1C), including for different Ub C-terminal thiol-reactive groups used.
In all cases, labeling could be blocked by inclusion offour Michael acceptor-derived probes [18, 19], vinyl
methyl sulfone (HAUbVS), vinyl methyl ester (HAUb- the alkylating agent N-ethyl-maleimide (NEM) (data not
shown), consistent with the presence of an active siteVME), vinyl phenyl sulfone (HAUbVSPh), and vinyl cya-
nide (HAUbVCN), and three alkylhalide-containing inhib- cysteine residue in the enzymes modified. Addition of
HAUb to the lysate (Figure 2, lane 2) resulted in efficientitors, chloroethyl (HAUbCl), bromoethyl (HAUbBr2), and
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thiol-reactive group in the active site is necessary for
optimal reactivity and that this property may be ex-
ploited to achieve selectivity.
Enzymes Modified by HAUb-Derived Probes
Are Part of Multiprotein Complexes
To isolate the proteins modified by HAUbVS, we immu-
noprecipitated labeled proteins from EL4 lysates using
anti-HA antibody bound to agarose beads as outlined
in Figure 3A. EL4 lysates were incubated with HAUbVS
and either denatured with SDS to dissociate noncova-
lent protein complexes or left untreated. These samples
were then subjected to immunoprecipitation with an im-
mobilized anti-HA antibody.
Modification with HAUbVS (denaturing conditions,
Figure 3B, lane 3) resulted in a labeling profile similar
to that observed in anti-HA immuno-blots (Figure 2, lane
6). Recovery of most immunoprecipitated polypeptides
was abolished by inclusion of a 3-fold molar excess
of untagged UbVS, demonstrating specificity for UbVS.
Samples immunoprecipitated under native conditions
(Figure 2, lane 4) contained not only the proteins ob-
served in the denatured sample, but also more than 10
Figure 2. Different HAUb-Derived Active Site-Directed Probes
additional prominent polypeptides (Figure 3B, lane 4,Show Distinct Labeling Profiles
indicated with asterisks). Competition with untaggedEL4 cell lysates (20 g) were incubated with 0.5 M of HAUb
UbVS (Figure 3B, lane 5) reduces their recovery, showingHAUbVS, HAUbVME, HAUbVSPh, HAUbBr2 or 1 M of HAUbCN,
that these proteins associate specifically with enzymesHAUbCl, HAUbBr3 as indicated. The labeled proteins were resolved
by 8% reducing SDS-PAGE and immunoblotted with anti-HA anti- modified by HAUbVS.
body. Polypeptides referred to in the text are indicated by arrow-
heads.
Identity of Enzymes Modified by HAUbVS
and Their Associated Factors
In yeast, the availability of deletion mutants allowedformation of poly-Ub conjugates, while such high molec-
ular weight conjugates were not observed upon treat- the identification of all targets of [125I]-UbVS [14]. While
radiolabeled [125I]-UbVS allowed us to demonstrate thement of the lysate with HAUb-derived probes.
Treatment of the lysate with HAUbVS (Figure 2, lane multiplicity of mammalian targets for this probe, the
identity of most modified polypeptides could not be6) produced a labeling pattern similar to that observed
with [125I]-UbVS [14], further confirming that the HA tag established. Incorporation of an HA epitope tag into
UbVS allows the retrieval of covalently modified en-does not hamper the recognition of HAUbVS by DUBs.
Inspection of the profile in Figure 2 shows comparable zymes for identification. The identity of polypeptides
from a HAUbVS-treated, nondenatured sample is shownlabeling intensity for the cluster of polypeptides around
MW 140 kDa (arrow 1) for all probes containing a Michael in Figure 3C and Tables 1 and 2. In all, 16 DUBs and 12
of the 18 known subunits of the 19S lid and base wereacceptor (Figure 2, lanes 6–9). For these proteins, the
nature of the electrophilic substituent does not affect identified (Figure 3B; Tables 1 and 2). The recovery of
19S cap subunits is in agreement with the known bindinglabeling efficiency. In contrast, for the cluster of poly-
peptides at MW 130 (Figure 2, arrow 2), significant differ- of USP14 and UCH37 (both labeled by HAUbVS) to the
19S complex [14, 21, 22]. Association of other labeledences in labeling efficiency are observed when different
Michael acceptors are used. Therefore, for a given DUB, DUBs with the 19S regulatory complex cannot be ex-
cluded at this point.not all probes are equally effective (see also Figure 2,
arrow 3). The labeling pattern was relatively insensitive Some DUBs were identified in several forms differing
in their molecular weight (Table 1). Modification byto the size of the substituent present in the Michael ac-
ceptor compounds (compare HAUbVS and HAUbVSPh). HAUbVS is predicted to increase the size of a DUB
by approximately 10 kDa and the resulting branchedThe alkyl halide-containing probes (HAUbBr2, HAUbCl,
HAUbBr3) modify a subset of the polypeptides labeled polypeptide may migrate at a larger apparent molecular
weight. The presence of different molecular weight spe-by the Michael acceptors, with the single exception of
a unique polypeptide around 40 kDa modified by cies may be also due to conjugation of Ub to the
HAUbVS-modified protein, since polyubiquitination oc-HAUbBr2 (Figure 2, arrow 4). In this case, it cannot be
excluded that the labeling takes place via an aziridine curs under the conditions used in the assay (Figure 2A,
lane 2). Proteolysis is unlikely to be a significant factor,intermediate. Interestingly, HAUbBr3, in which the reac-
tive position is one carbon removed from the preferred since most observed molecular weights exceed the
masses predicted from primary sequence. Proteins notsite of attack by a hydrolase, displays more restricted
reactivity, modifying only 4 distinct proteins (Figure 2, currently linked to the ubiquitin-proteasome system
were also recovered under native conditions (Figure 3C;lane 4). This suggests that precise positioning of the
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Figure 3. Protein Complexes Containing HAUbVS Modified Enzymes Can Be Recovered by Anti-HA Immunoprecipitation
(A) Outline of the immunoprecipitation experiment to recover proteins covalently modified by HAUbVS with (nondenatured) or without (denatured)
their interacting partners.
(B) Silver stain of HAUbVS modified proteins under different conditions. Five milligrams of lysate were treated with 6.6 g of HAUb (lane 2),
HAUbVS (lane 3), and a 3-fold molar excess of untagged UbVS as a competitor (lane 5). “Denatured” samples (lane 4) were treated with 0.4%
SDS prior to the addition of anti-HA agarose. Bound proteins were eluted with 50 mM glycine (pH 2.5), resolved by 8% reducing SDS-PAGE,
and silver stained. 19S subunits are indicated by asterisks.
(C) Identity of enzymes and associated proteins bound by HAUbVS. Nondenatured samples treated with HAUbVS were prepared as described
in Figure 3. Silver or Coomassie stained bands were excised from gels, proteins were in-gel digested with trypsin and the eluted peptides
were sequenced on a Micromass MS/MS Q-TOF MICRO instrument. Proteins were identified by searching the results against the SwissProt,
Tremble, and TrembleNew databases using the ProteinLynx GlobalServer software 1.1 (Micromass). Any matches with scores of 100 or above
were considered significant. Alternatively, the obtained MS results were search against the NCBInr database using Mascot (MatrixScience).
Deubiquitinating enzymes are indicated in bold; ND, not determined; bkg, background.
Table 2). A number of these polypeptides interact with Figure 4 shows the profile of polypeptides immunopre-
cipitated from lysates treated with HAUbVS, HAUbVMERNA. RNA binding hnRNP proteins and ribosomal sub-
units are common contaminants in affinity-purified ma- and HAUbBr2 under native (Figure 4A) or denaturing
(Figure 4B) conditions. As observed in immunoblot (Fig-terial [23] and are recovered in our experiments. Most
of the identified proteins are linked to RNA processing ure 2), HAUbVME immunoprecipitates a larger number
of proteins than HAUbVS (Figure 4B, compare lanes 3and transport, and some of them might indeed interact
directly with DUBs. and 4). HAUbBr2 shows a more restricted labeling profile
with a unique polypeptide at 42 kDa (Figure 4B, lane 5,
arrowhead). MS/MS analysis showed that HAUbVMEDUBs Exhibit Selectivity for Different
HAUb-Derived Probes modifies USP11, USP12, USP13, USP25, USP28,
CYLD1, and a USP fragment, KIAA891, in addition to allHAUbVS appears to be highly specific for DUBs. How-
ever, introduction of other chemical substituents at the C the DUBs labeled by HAUbVS (Table 1). Despite the
larger number of DUBs labeled by HAUbVME, the major-terminus of Ub may allow the modification of additional
enzyme classes. To address this question, we identified ity of the associated proteins recovered in the nondena-
tured samples appear to correspond to the subunitsthe enzymes modified by HAUbVME and HAUbBr2,
since the labeling patterns for these inhibitors deviate of the 19S proteasome cap as judged from the silver-
stained sample (Figure 4A, lane 4).significantly from that observed for HAUbVS (Figure 2).
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Table 2. Proteins That May Associate with DUBs
Accession Predicted MW Observed MW Number of Sequence
Protein Number (kDa) (kDa) Matches Coverage (%) Remarks
S1 (Rpn2) Q99460 (h) 106 115 3 6.2 19S cap subunit (base)
S2 (Rpn1) Q13200 (h) 100 97 18 26.2 19S cap subunit (base)
S3 (Rpn3) P14685 60.7 61 16 33.2 19S cap subunit (lid)
S4 (Rpt2) Q03527 (h) 49 59 12 33.6 19S cap subunit (base)
S7 (Rpt1) P46471 48.5 48 4 10.2 19S cap subunit (base)
S9 (Rpn6) O00495 (h) 47.4 48 1 2.8 19S cap subunit (lid)
S10B(Rpt4) Q92524 (h) 44 43, 44 8 26.7 19S cap subunit (base)
S10A (Rpn7) Q99JI4 45.5 44 20 47.3 19S cap subunit (lid)
S11 (Rpn9) Q9WVJ2 42.8 41 16 43.4 19S cap subunit (lid)
S12 (Rpn8) P26516 36.5 39 3 15 19S cap subunit (lid)
S13 (Rpn11) O35593 34.5 34 1 4.2 19S cap subunit (lid)
DNA methyltransferase P13864 183 200 5 16.4 Dmnt1
DNA pol1 subunit CAC96831 98.5 115 1 1.1
RNA helicase A O70133 149 150 10 8 binds mRNAa
RNAbp EWS Q01844 68 75 1 2.1 binds mRNAa
PolyA-BP P11940 70 69 13 24.5 binds mRNAa
RNA helicase PL10 P16381 73 73 2 3.9 binds mRNAa
thioredoxin-like CAC40691 37 34 1 3.9
aminotransferase Q98JR5 44 39 1 2
aInterPro database (http://www.ebi.ac.uk/interpro/).
Proteins were isolated from nondenatured samples modified with HAUbVS and sequenced by MS/MS as described in the text. Only proteins
absent from the denatured preparations are given; those occurring in both denatured and nondenatured samples were considered nonspecific.
Accession numbers, number of matches, and percent coverage are as in Table 1. 19S lid and base assignments are based on [29].
Interestingly, 19S subunits were not recovered from UCH37 and USP14 (Figure 4A, asterisks). The denatured
and nondenatured HAUbBr2 samples (compare lane 5nondenatured samples treated with HAUbBr2 (Figure
4A, lane 5). This is consistent with the inability of in Figures 4A and 4B) look remarkably similar, indicating
that enzymes labeled by HAUbBr2 do not have strongHAUbBr2 to modify the proteasome bound DUBs
noncovalent interacting partners. The unique 42 kDa
polypeptide present in both denatured and native sam-
ples was identified as a predicted protein containing an
ovarian tumor (OTU)-like domain (HSPC263, Table 1).
This domain is present in a variety of proteins and has
been predicted to encode a novel cysteine protease
signature [17]. Its modification by HAUbBr2 is the first
demonstration of enzymatic activity for an OTU-domain
containing protein, such as HSPC263. Labeling of this
polypeptide is diminished by NEM treatment and com-
peted by inclusion of 100-fold excess of unmodified Ub
(data not shown), consistent with a requirement for an
active site cysteine and at least some measure of speci-
ficity for Ub.
Discussion
The Ub-proteasome system includes a large number
of deubiquitinating enzymes, many of them known by
sequence similarity only. The biological role of most
of these enzymes remains unknown. Elucidation of the
function of individual DUBs is complicated by a consid-
erable overlap in substrate specificity as indicated by
deletion studies in yeast, in which a high level of redun-
dancy between DUBs is observed [24] (R. Casagrande,
A.B., and H.P., unpublished data). Alternative ap-
proaches are clearly required, and a step in this direction
Figure 4. Proteins Bound by HAUbVME and HAUbBr2 under Nonde-
is the development of DUB-specific inhibitors based onnaturing (A) or Denaturing (B) Conditions
C-terminal modifications of Ub [14, 21, 25].
Samples were prepared as described in Figure 3; equal amounts of
We identify DUBs on the basis of their reactivity to-different inhibitors were used in all reactions. Proteins were visual-
ward suicide substrates composed of three elements:ized by silver stain. Known proteasome-associated DUB are indi-
cated by asterisks; OTU-protease is indicated by an arrowhead. the Ub moiety which confers specificity for the DUB
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family, a thiol-reactive group that allows covalent mech-
anism-based trapping of the active site cysteine, and
an epitope tag that allows nonradioactive detection of
modified DUBs as well as their isolation and subsequent
identification. The use of several different electrophilic
moieties allowed us to target enzymes that do not react
with UbVS [14].
We observed that different electrophiles at the C ter-
minus of Ub vary considerably in their ability to react
with individual DUBs (Figure 2), indicating that the active
sites of DUBs belonging to the same family are not
equivalent and that it may ultimately be possible to de-
sign more selective probes. As suggested by the poly-
peptide profile in immunoblots, HAUbVME exhibited the
broadest reactivity, while HAUbBr2 modified a more re-
stricted number of DUBs as well as a novel protein not
related to DUBs by sequence. The enzymatic activity of
nine proteins, predicted based on sequence homology,
could thus be established experimentally.
Tandem mass spectrometry-based analysis indicated
that HAUb-derived probes modify 3 members of the Ub
Figure 5. Sequence Comparison of the UBP FamilyC-terminal hydrolase (UCH) and 20 members of the Ub-
Catalytic domains of the UBPs annotated in SwissProt or GenBankspecific protease (UBP) families of DUBs in EL4 cells
databases or sequenced in our analysis were assigned based on
(Table 1). At least 1 other UCH–BAP1 and as many as ProSite parameters (http://us.expasy.org/prosite, profile PS50235).
20 other UBPs are encoded by the mouse (and human) Catalytic domains were aligned using MegAlign program of the
genome [6]. We analyzed the sequences of the UBP DNAStar software package (using a Clustal V algorithm PAM250
matrix); all catalytic residue signatures were well aligned, exceptfamily enzymes to determine whether the UBPs modified
CYLD1, for which a recognizable His box could not be found. Aby HAUb-derived probes share features that can ac-
neighbor-joining phylogenetic tree [37] was then generated basedcount for their reactivity. Figure 5 compares the 34 UBPs
on the alignment. Enzymes targeted by HAUb-derived probes
annotated by SwissProt and GenBank databases, a sub- (HAUbVS, HAUbVME, and HAUbBr2) are shaded. Accession num-
set of which was identified in our experiments as active bers of labeled UBPs are given in Table 1, accession numbers of
DUBs. A phylogenetic tree derived from an alignment unmodified UBPs are as follows (SwissProt accession numbers are
given, unless indicated otherwise, h-human sequence): USP9Y-hof the catalytic domains shows that the UBPs modified
(O00507), DUB2 (O55190), DUB2A (Q923V2), DUB1 (Q61068), USP6by all three inhibitors (shaded boxes) form several clus-
hr (P35125), USP2 (O88623), USP23 (Q9QZL6), USP22 hr (Q9UPT9),ters. Not all enzymes within a particular cluster are la-
USP20 hr (Q9Y2K6), VDU1 (AAL78316-GenBank), USP3 hr (Q9Y6I4),
beled by the same inhibitors; for instance, USP5 is modi- USP26 (Q99MX1), USP29 (NP_067298-GenBank), USP18 (Q9WTV6).
fied by HAUbVS, HAUbVME, and HAUbBr2, while a
related enzyme, USP13, is targeted by HAUbVME only
teins, termed the ovarian tumor domain (OTU) after the(Table 1). No significant shared sequences (other than
Drosophila ovarian tumor gene in which it was initiallythose common to all UBPs) were detected among the
characterized [27]. None of the OTU domain proteins20 UBPs labeled by HAUb-derived probes, suggesting
have known biochemical function, but a sequence com-that no additional unique motifs are required for modifi-
parison study identified a novel cysteine protease signa-cation of UBPs by HAUb-derived probes. The lack of
ture within this domain, which shares limited homologyshared sequence determinants is underscored by the
with the papain-type proteases [17]. The HSPC263 pro-modification of CYLD1 (a tumor suppressor mutated
tein contains conserved residues predicted to form thein cylindromatosis [8]) by HAUbVME despite its limited
active site of this protease family (Asp92, Cys95, andsimilarity to the UBP family.
His269), and its modification by HAUbBr2 is inhibitedLabeling of extracts from other cell lines shows differ-
by alkylation with NEM, showing that modification isent profiles of targeted polypeptides (data not shown),
dependent on an active site cysteine. This is the firstsuggesting that some of the UBPs that we do not detect
demonstration of enzymatic activity for this novel prote-are simply not expressed in the cell line used in this
ase superfamily. HSPC263 is also detected in nondena-study. The lack of labeling of some of the UBPs may
tured samples treated with HAUbVS. In this case, thealso be due to low affinity of certain enzymes for mono-
protein is not modified by HAUbVS, since it is found at itsmeric Ub. A subset of DUBs may not interact with Ub
predicted molecular weight of 32 kDa. This observationat all, but have Ub-like proteins as their true substrates,
suggests that HSPC263 is part of a complex with anas has been reported for USP18, which is specific for
active DUB. While HSPC263 does not contain any otherUCRP [26] and is not modified by our probes.
recognizable domains, several proteins containing anMost polypeptides modified by HAUb-derived probes
OTU domain possess UIM, UBA, or Ubl domains, andcontain known sequence motifs characteristic of the
in one case, a catalytic signature of a UBP [17] (availableUBP or UCH enzymes families, but other enzymes that
also in the InterPro database: http://www.ebi.ac.uk/can react with the C terminus of Ub may exist. One such
interpro/). This suggests a further link of the OTU super-protein (HSPC263) is modified by HAUbBr2. This protein
contains a conserved domain present in 80 other pro- family to the Ub system.
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All proteins covalently modified by HAUb-derived groups demonstrates that the reactivity of these
probes can be fine-tuned, which opens the way forprobes are hydrolases. Ub-activating and conjugating
enzymes are not targeted by our probes. The chemistry designing inhibitors that could target individual en-
zymes more selectively. The intein-based method fa-of the E1 and E2 enzymes and their low affinity for free
Ub makes them poor candidates for modification with cilitates the coupling of a variety of chemical moieties
onto the C terminus of Ub and potentially other pro-HAUb-based probes (for review see [5]). The HECT-
domain E3s are the only other enzymes in the Ub system teins. Additionally, HAUb-derived probes with broad
reactivity, such as HAUbVME, can be used to rapidlyknown to form a covalent thioester bond with the C
terminus of Ub [28]. Modification of the purified HECT screen the activity of many DUBs in cells subjected to
different experimental conditions or in tissue samplesdomain of E6-AP by UbVS is in fact observed in the
presence of excess inhibitor (data not shown). Neverthe- from healthy or diseased individuals. More generally,
their use allows the unambiguous assignment of par-less, we do not recover E6AP or related E3s using HAUb-
based probes, suggesting that under our experimental ticular enzymatic function to open reading frames.
conditions their modification is undetectable in cell ly-
Experimental Proceduressates, where enzymes with higher affinity for Ub and
greater reactivity toward the probes would react prefer-
Methanesulfonylmethyl-phosphonic acid diethyl ester and benzene-
entially. sulfonylmethyl-phosphonic acid diethyl ester were synthesized ac-
Affinity purification of DUBs under native conditions cording to literature procedures [18, 19, 33] (see Supplemental Data
allows recovery of associated proteins (Figure 3). The for synthesis details). Slide-a-lyzer dialysis membranes were from
Pierce. NMR spectra were recorded on a Varian 200 MHz spectrom-majority of polypeptides recovered together with DUBs
eter; mass spectra were recorded on an electrospray LCZ LC-MSmodified by HAUbVS and HAUbVME are subunits of
instrument (LC HP1100 Hewlett Packert, MS Micromass, UK)the 19S cap of the proteasome. DUBs are known to
equipped with a Waters DeltaPak C4 (3.9x150 mm) column.
associate with the 26S proteasome and are thought
to remove poly-Ub chains from proteins targeted for Plasmid Construction
degradation. While several DUBs may bind the protea- pTYB-HAUb plasmid was constructed by cloning the sequence of
human Ub (lacking Gly76) into the pTYB2 vector (New England Bio-some [29], only UCH37 and USP14 have been shown to
labs) to generate an in-frame fusion with the intein and chitin bindingbind the 26S complex in a stable fashion and may be
domain. The HA tag was introduced by inserting an oligonucleotideresponsible for editing poly-Ub chains and Ub recycling,
cassette into the NdeI site at the 5end of the Ub sequence.
respectively [14, 21]. These two proteins are modified
by HAUbVS and HAUbVME and are most likely responsi- Synthesis of HAUb75-MESNa
ble for the observed copurification of 19S subunits in our Ub-intein-chitin domain fusion protein was expressed in E. coli (2
hr induction with 0.5 mM IPTG at 30C). Cells pellets were resus-preparations. Interestingly, 19S subunits do not copurify
pended in 50 ml 50 mM HEPES pH 6.5, 100 mM NaOAc, 50 Mwith enzymes modified by HAUbBr2, suggesting that
PMSF and lysed by french press (1500 psi). The clarified cell extractthe 11 DUBs modified by this HAUb-derived probe do
was loaded onto a 15 ml chitin bead (New England Biolabs) columnnot associate in a stable manner with the 19S cap. Our at a flow rate of 0.5 ml/min. The column was washed with 60 ml of
data suggest that modified DUBs do not stably associ- lysis buffer followed by 25 ml of lysis buffer containing 50 mM
ate with other multisubunit complexes such as the COP9 -mercaptoethanesulfonic acid sodium salt (MESNa) and incubated
overnight at 37C for the induction of on-column cleavage. HAUb75-signalosome, which shares homology with the 19S cap
MESNa thioester was eluted with 25 ml of lysis buffer and concen-[4]. Recent reports have demonstrated that 19S proteins
trated: approximately 2.5 mg of protein was recovered from a 1Lplay a nonproteolytic role in nucleotide excision repair
culture. The N-terminal Met of the HA-tag was frequently processedand transcription elongation [30]. In vivo, the base of the off, giving a mixture of two proteins that behaved identically in
19S complex can function independently of the larger labeling experiments.
complex and is implicated in RNA polymerase II-depen-
dent transcription [31]. This may explain why many RNA Synthesis and Purification of HAUb-Derived Active Site
Thiol-Reactive Probesbinding proteins were isolated under native conditions
HAUbCl, HAUbBr2, HAUbBr3(Table 2). Additionally, a recent study suggests a role
To a solution of HAUb75-MESNa (1-2 mg/mL) in column buffer (500for USP8 (UbpY) and USP4 (UNP) in the regulation of
l) was added 0.2 mmol of the desired haloalkylamine haloacid salt
short-lived mRNA degradation [32]. DUBs could there- and 100l of 2.0 M aqueous NaOH and the mixture was immediately
fore play a regulatory role in transcription and RNA me- vortexed. After 20 min at room temperature. 100 l of 2.0 M aqueous
HCl was added and the solution was dialyzed against 50 mM NaOActabolism processes.
(pH 4.5) in a 3.5 ml Pierce Slide-a-lyzer cassette (3500 MWCO) for
2 hr. The resulting product (90% conversion estimated from LC-
MS) was divided into aliquots and stored at 80C (no significantSignificance
deterioration is observed for several months of storage except for
HAUbBr2, which is more unstable).
Deubiquitinating enzymes are emerging as a new class HAUbVME, HAUbVS, HAUbVCN
of regulators in the ubiquitin-proteasome system. The To a solution of HAUb75-MESNa (1-2 mg/ml, 500l) was added 0.125
mmol of the desired Michael acceptor as para-toluene sulfonic acidchemistry-based proteomics approach presented in
salt followed by 75 l of 2M N-hydroxy succinimide and 125 l 2 Mthis study allows isolation, identification, and demon-
NaOH. The mixture was incubated at 37C for 2 hr and reactionstration of enzyme activity using specific probes
progress was monitored by LC-MS to give the desired productsagainst DUBs. We not only find novel enzymes of the
with 50%–60% conversion. The reaction mixture was neutralized
DUB family, but also demonstrate DUB-like enzymatic by the addition of 125l of 2 M HCl and dialyzed as described above.
activity of a novel putative superfamily of proteases. HAUbVSPh and HAUb were synthesized similarly (see Supplemental
Data).Labeling profiles obtained with different thiol-reactive
Functional Proteomics of Deubiquinating Enzymes
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